Meeting
2024 ASCO Gastrointestinal Cancers Symposium
Tissue factor: A link between metastatic colorectal cancer and thrombosis in patients in the CALGB (Alliance)/SWOG 80405 trial.
Authors
Sandra Algaze
Division of Medical Oncology, USC Norris Comprehensive Cancer Center, Keck School of Medicine, Los Angeles, CA
Sandra Algaze , Yan Yang , Joshua Millstein , Shivani Soni , Francesca Battaglin , Priya Jayachandran , Jae Ho Lo , Pooja Mittal , Karam Ashouri , Lesly Torres-Gonzalez , Goar Smbatyan , Wu Zhang , Howard Liebman , Heinz-Josef Lenz
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session C: Cancers of the Colon, Rectum, and Anus
Track
Colorectal Cancer,Anal Cancer
Sub Track
Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 42, 2024 (suppl 3; abstr 198)
DOI
10.1200/JCO.2024.42.3_suppl.198
Abstract #
198
Poster Bd #
M6
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Causal modeling of CALGB 80405 (Alliance) to identify network drivers of metastatic colorectal cancer (CRC).
First Author: Rahul K Das
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Myostatin/activin pathway gene expression and single nucleotide polymorphisms (SNPs) in metastatic colorectal cancer (mCRC).
First Author: Karam Ashouri
Poster
2022 ASCO Annual Meeting
Predictive value of MAOB gene expression for targeted therapy in patients (pts) with metastatic colorectal cancer (mCRC) enrolled in CALGB (Alliance)/SWOG 80405.
First Author: Wu Zhang
Poster
2020 ASCO Virtual Scientific Program
Tumor mutational load, microsatellite instability and actionable mutations in metastatic colorectal cancer: Results from the TRIBE2 study.
First Author: Carlotta Antoniotti